
Novavax Vaccine Approved, But With Strict Access Limits
The FDA has approved the Novavax COVID-19 vaccine, but with significant restrictions. Only adults over 12 with pre-existing conditions increasing their COVID-19 risk will have access. This decision, criticized by some experts as "incredibly disappointing," limits availability to healthy adults and raises concerns about future COVID-19 variants. ...








